These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 16775331)

  • 21. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
    Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
    Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
    Feng Z; Cerveny M; Yan Z; He B
    J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production.
    Komatsu T; Takeuchi K; Yokoo J; Gotoh B
    Virology; 2004 Jul; 325(1):137-48. PubMed ID: 15231393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli.
    Zinzula L; Esposito F; Mühlberger E; Trunschke M; Conrad D; Piano D; Tramontano E
    Protein Expr Purif; 2009 Jul; 66(1):113-9. PubMed ID: 19233284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.
    Prins KC; Cárdenas WB; Basler CF
    J Virol; 2009 Apr; 83(7):3069-77. PubMed ID: 19153231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.
    Andersson I; Karlberg H; Mousavi-Jazi M; Martínez-Sobrido L; Weber F; Mirazimi A
    J Med Virol; 2008 Aug; 80(8):1397-404. PubMed ID: 18551619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
    Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
    J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels.
    Roth-Cross JK; Martínez-Sobrido L; Scott EP; García-Sastre A; Weiss SR
    J Virol; 2007 Jul; 81(13):7189-99. PubMed ID: 17459917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
    Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.
    Jin H; Yan Z; Prabhakar BS; Feng Z; Ma Y; Verpooten D; Ganesh B; He B
    J Gen Virol; 2010 Feb; 91(Pt 2):352-61. PubMed ID: 19828757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
    Ilinykh PA; Lubaki NM; Widen SG; Renn LA; Theisen TC; Rabin RL; Wood TG; Bukreyev A
    J Virol; 2015 Aug; 89(15):7567-83. PubMed ID: 25972536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of antigenic determinant profiles of the Ebola virus VP35 protein N-terminal region using its short recombinant fragments].
    Rudzevich TN; Ternovoĭ VA; Kazachinskaia EI; Razumov IA; Chepurnov AA; Loktev VB; Netesov SV
    Mol Gen Mikrobiol Virusol; 2003; (2):38-40, backcover. PubMed ID: 12800775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
    Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production.
    Chew T; Noyce R; Collins SE; Hancock MH; Mossman KL
    Mol Immunol; 2009 Jan; 46(3):393-9. PubMed ID: 19038458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
    Biedenkopf N; Lier C; Becker S
    J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.